FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions relates to field of pharmaceutics and medicine and deal with pharmaceutical substance, which represents salt of L-lysine amino acid and escin, with escin representing mixture of escin Ia, escin Ib, isoescin Ia and isoescin Ib, where ratios of escin Ia and escin Ib sum to isoescin Ia and isoescin Ib sum constitutes 1.0-4.0:4.0-1.0, preferably 3:2. Pharmaceutical composition, containing said substance, possesses anti-oedematous and anti-inflammatory action.
EFFECT: group of inventions provides safe therapeutic profile with reduced frequency of development of side effects.
3 cl, 5 ex, 6 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION CONTAINING LYSINE AND ENZYMES: LYSOZYME, DEOXYRIBONUCLEASE AND/OR PEROXIDASE FOR EXTERNAL TREATMENT AND PREVENTION OF INFECTIONS CAUSED BY TYPE 1, 2 HERPES VIRUSES, AND BACTERIAL COMPLICATIONS CAUSED BY HERPETIC INFECTION | 2013 |
|
RU2535053C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING LYSINE, PROLINE AND TRITERPENIC ACID DERIVATIVES FOR TREATING AND PREVENTING VIRAL INFECTIONS CAUSED BY RNA- AND DNA-CONTAINING VIRUSES, SUCH AS: INFLUENZA, HERPES, HERPES ZOSTER, HUMAN PAPILLOMA, ADENOVIRUSES, AS WELL AS BACTERIAL INFECTIONS CAUSED BY GRAM-POSITIVE AND GRAM-NEGATIVE MICROORGANISMS | 2013 |
|
RU2535052C1 |
| CONTACT-TYPE PURGATIVE PREPARATION, PHARMACEUTICAL COMPOSITION UPON ITS BASIS AND METHOD FOR PREVENTING AND TREATING CONSTIPATIONS AND AFFECTED BIORHYTHM OF DEFECATION | 2004 |
|
RU2245161C1 |
| PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF INFECTIOUS-INFLAMMATORY DISEASES | 2021 |
|
RU2794363C1 |
| PHARMACEUTICAL COMPOSITION WITH ANALGESIC ACTIVITY IN INJECTION FORM (VERSIONS) | 2013 |
|
RU2563211C2 |
| STABLE LIQUID PHARMACEUTICAL COMPOSITION OF 3-(2,2,2-TRIMETHYLHYDRAZINIUM) PROPIONATE-2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE DISUCCINATE COMPLEX, HAVING ANTIHYPOXIC, ANTIOXIDANT AND ADAPTOGENIC ACTION | 2013 |
|
RU2527347C1 |
| ANTIMICROBIAL PRESERVATIVES FOR OBTAINING MULTIDOZE COMPOUNDINGS USING β-CYCLODEXTRINES FOR LIQUID MEDICINAL FORMS | 2005 |
|
RU2332997C2 |
| METHOD FOR PREPARING ANTIBIOTIC CARMINOMYCINE OR ITS HYDROCHLORIDE | 2004 |
|
RU2260011C1 |
| N,N'-DIACETYLCYSTINE ORGANIC SALTS, METHODS OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT | 1992 |
|
RU2135468C1 |
| PREPARATION "VENOGEPANOL" FOR TREATMENT AND PROPHYLAXIS OF VESSEL AND TISSUE PATHOLOGICAL INJURE | 2003 |
|
RU2238737C1 |
